David Margulies

David Margulies has an extensive work experience. David is currently the Director at Variantyx since 2021. Prior to that, they were the Director at Travera since 2017, co-Founder, Director (until July 2020), and Chairman (until January 2020) at Q-State Biosciences since 2014, Ass't Professor, Medicine at Harvard Medical School since 2011, Investor/Director at QurAlis since 2017, Vice President Strategic Alliances at Boston Children's Hospital since 2011, Director at Claritas Genomics since 2013, Director at Circulation (now LogistiCare) since 2016, Director at Commonwealth Care Alliance since 2005, and Investor/Director at OBMedical Company (now Philips Healthcare (NYSE: PHG)) since 2012.

David Margulies obtained their MD from Harvard Medical School in 1977, after completing their BA in Molecular Biology from Amherst College in 1973.